TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
ADAG

Adagene Inc

Healthcare · Biotechnology

3.20$ +9.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Adagene Inc (ADAG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 134 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADAG
Line item Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q2 25 Q4 25 Q1 26 Q2 26
135 135 116 116 101 101 101 89 67 78 78 134
133 133 113 113 99 99 99 88 65 77 77 132
129 129 110 110 96 96 96 85 63 75 75 128
129 129 110 110 96 96 96 85 63 – 75 128
0.6 0.4 – 0.2 – 0.0 0.0 0.0 0.0 – 0.0 0.2
– – – – – 0.0 0.0 – – – – –
2.5 2.5 – – – – – – – – – –
53 53 45 45 44 44 44 39 29 43 43 28
39 39 31 31 40 40 40 38 29 25 25 26
12 12 8.6 8.6 16 16 16 18 6.8 – 5.1 4.9
4.5 4.5 3.1 3.1 3.4 3.4 3.4 4.2 3.6 2.9 2.9 16
– 13 – 14 – 4.6 – 0.4 – 1.1 – 1.0
83 83 71 71 57 57 57 51 38 35 35 106
-263 -263 -278 -278 -295 -295 -295 -311 -325 -329 -329 -345
35 35 35 35 35 44 35 37 38 59 38 45

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?